Traders Buy Large Volume of Owens & Minor Call Options (NYSE:OMI)

Owens & Minor, Inc. (NYSE:OMI) saw some unusual options trading on Monday. Traders acquired 9,860 call options on the company. This represents an increase of approximately 1,549% compared to the typical daily volume of 598 call options.

Insider Activity

In related news, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now owns 71,654 shares in the company, valued at approximately $1,791,350. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Jonathan A. Leon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $24.84, for a total value of $124,200.00. Following the completion of the transaction, the senior vice president now owns 84,673 shares in the company, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. Corporate insiders own 2.62% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

Hedge funds have recently bought and sold shares of the stock. Riverview Trust Co bought a new stake in Owens & Minor in the 1st quarter worth approximately $25,000. DekaBank Deutsche Girozentrale purchased a new position in Owens & Minor in the 3rd quarter worth $29,000. Quest Partners LLC bought a new stake in Owens & Minor in the fourth quarter worth $41,000. Hexagon Capital Partners LLC boosted its position in Owens & Minor by 1,240.2% during the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after buying an additional 1,451 shares during the period. Finally, GAMMA Investing LLC grew its stake in shares of Owens & Minor by 52.1% during the first quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock valued at $46,000 after buying an additional 563 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors.

Owens & Minor Trading Down 1.6 %

Owens & Minor stock opened at $18.91 on Wednesday. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.56 and a current ratio of 1.16. Owens & Minor has a fifty-two week low of $13.64 and a fifty-two week high of $28.35. The stock has a market cap of $1.45 billion, a P/E ratio of -37.08, a PEG ratio of 0.57 and a beta of 0.52. The firm’s fifty day moving average price is $25.14 and its 200-day moving average price is $21.56.

Owens & Minor (NYSE:OMI) last announced its earnings results on Friday, May 3rd. The company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The business had revenue of $2.61 billion for the quarter, compared to analyst estimates of $2.61 billion. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.05 EPS. Equities research analysts forecast that Owens & Minor will post 1.54 earnings per share for the current fiscal year.

Analysts Set New Price Targets

OMI has been the subject of several research reports. UBS Group reduced their price target on shares of Owens & Minor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday, January 29th. SVB Leerink assumed coverage on Owens & Minor in a report on Monday, February 26th. They set a “market perform” rating and a $24.00 price objective for the company. TheStreet upgraded Owens & Minor from a “d+” rating to a “c-” rating in a research note on Monday, March 4th. StockNews.com cut Owens & Minor from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, Robert W. Baird reduced their target price on shares of Owens & Minor from $28.00 to $24.00 and set a “neutral” rating for the company in a research note on Monday. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $23.29.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.